Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 1.85B | £ 588.00M | £ 1.29B | £ 765.00M | £ 1.63B |
Total Assets | £ 30.96B | £ 28.11B | £ 29.09B | £ 29.13B | £ 32.31B |
Total Debt | £ 10.26B | £ 9.94B | £ 10.07B | £ 11.26B | £ 11.95B |
Net Debt | £ 8.40B | £ 9.35B | £ 8.79B | £ 10.49B | £ 10.32B |
Total Liabilities | £ 23.48B | £ 22.22B | £ 23.15B | £ 24.10B | £ 26.79B |
Stockholders Equity | £ 6.86B | £ 5.33B | £ 5.35B | £ 4.45B | £ 4.87B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |